Inhibition effects of chlorimipramine on human brain U251 glioma cells and its potential mechanism
ZHU Xun1, WANG Jing-zhe1, CHEN Pin2, WANG Cun-zu1, XU Hui-zhong3, OUYANG Qi1
（1. School of Medicine, Jiangsu University, Zhenjiang Jiangsu 212013; 2. Department of Neurosurgery, Subei People′s Hospital, Yangzhou Jiangsu 225001; 3. Department of Neurosurgery, Dongtai People′s Hospital, Dongtai Jiangsu 224200, China)
Abstract：[Abstract]Objective: To explore the possible mechanism of chlorimipramine on human brain glioma U251 cell apoptosis. Methods: Using methyl thiazolyl tetrazolium(MTT) colorimetry with different concentrations of chlorimipramine to test the effects of chlorimipramine on human brain U251 glioma cells; based on the results, selecting two group of different concentrations for the detection of relevant indicators, including death count of trypan blue staining cell, apoptosis staining, the detection of flow cytometry. Additionally, Western blotting and immumofluorescence assay were conducted to examine the expression level of translocator protein(TSPO). DCFHDA probe was performed to examine the level of reactive oxygen species (ROS) and luciferase assay was applied to investigate cell mitochondrial membrane potential. Results: Based on the testing results of MTT, selecting chlorimipramine 57, 28.5 μmol/L, the concentrations of which have statistically significant differences; then putting them into the following tests: trypan blue staining, cell apoptosis staining, and flow cytometry. All the testing results confirmed that chlorimipramine had significantly inhibiting effects on human brain U251 glioma cells, and with a certain degree, the effects were associated with the drug concentration. Additionally, comparing with the control group, Western blotting analysis and immumofluorescence demonstrated that the expression level of TSPO was significantly increased in the groups of chlorimipramine（P<0.05).The level of ROS was significantly higher, but ATP quantity decreased significantly（P<0.05). Conclusion: Chlorimipramine could significantly inhibit human U251 glioma cell growth, promote apoptosis by increasing the expression level of TSPO,ROS and decreasing ATP quantity. Chlorimipramine has good antiglioma effects, and could be used as a kind of candidate drug for the treatment of glioma chemotherapy.
朱勋1，王菁哲1，陈品2，王存祖1，许慧中3，欧阳琦1. 氯丙咪嗪对脑胶质瘤U251细胞活性的抑制作用及机制[J]. 江苏大学学报:医学版, 2016, 26(02): 132-136.
ZHU Xun1, WANG Jing-zhe1, CHEN Pin2, WANG Cun-zu1, XU Hui-zhong3, OUYANG Qi1. Inhibition effects of chlorimipramine on human brain U251 glioma cells and its potential mechanism. Journal of Jiangsu University(Medicine Edition), 2016, 26(02): 132-136.
\[1\]Bielecka AM, Obuchowicz E. Antidepressant drugs as a complementary therapeutic strategy in cancer\[J\]. Exp Biol Med (Maywood), 2013, 238(8):849-858.\[2\]Frick LR, Rapanelli M. Antidepressants: influence on cancer and immunity\[J\]. Life Sci, 2013, 92(10):525-532.\[3\]Rooprai HK, Christidou M, Pilkington GJ. The potential for strategies using micronutrients and heterocyclic drugs to treat invasive gliomas\[J\]. Acta Neurochir(Wien), 2003, 145(8): 683-690.\[4\]Daley E, Wilkie D, Loesch A, et al. Chlorimipramine: a novel anticancer agent with a mitochondrial target\[J\]. Biochem Biophys Res Commun, 2005, 328(2):623-632.\[5\]Veenman L, Shandalov Y, Gavish M. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis\[J\]. J Bioenerg Biomembr, 2008, 40(3):199-205.\[6\]许慧中, 王存祖. 脑胶质瘤中TSPO与细胞凋亡的关系\[J\]. 国际神经病学神经外科学杂志, 2010, 37(6): 578-580.\[7\]Levin E, Premkumar A, Veenman L, et al. The peripheraltype benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line\[J\]. Biochemistry, 2005, 44(29):9924-9935.\[8\]Pilkington GJ, Parker K, Murray SA. Approaches to mitochondrially mediated cancer therapy\[J\]. Semin Cancer Biol, 2008, 18(3):226-235.\[9\]Beaney RP, Gullan RW, Pilkington GJ. Therapeutic potential of antidepressants in malignant glioma: clinical experience with clomipramine\[J\]. J Clin Oncol (Meet Abstr)，2005，23（16S）:1535.\[10\]Parker KA, Glaysher S, Hurren J, et al. The effect of tricyclic antidepressants on cutaneous melanoma cell lines and primary cell cultures\[J\]. Anticancer Drugs, 2012, 23(1):65-69.\[11\]Bilir A, Erguven M, Oktem G, et al. Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma\[J\]. Int J Oncol, 2008, 32(4):829-839.\[12\]Higgins SC, Pilkington GJ. The in vitro effects of tricyclic drugs and dexamethasone on cellular respiration of malignant glioma\[J\]. Anticancer Res, 2010，30(2):391-397
2016, Vol. 26 
